Insecticides India Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹1,491 Cr
- P/E
- 11.92
- ROE
- 12.02%
- PEG
- 0.39
- Price to sales
- 0.73
- Debt to equity
- 0.13
- 52W high / low
- ₹765 / ₹512
- Sales growth (5Y)
- 8.55%
- EBITDA margin
- 10.17%
- Net profit margin
- 6.47%
- Promoter holding
- 72.30%
- Sales (last year)
- ₹2,060 Cr
Insecticides India is into manufacturing of agrochemicals (technicals and formulations) and biological and household products. They cater to Indian market where they directly sell to the end consumer and also sell technicals and formulations to the companies who are in the business of formulation. They also export to 30 countries with more than 100 customers through registrations. IIL has more than 75 registrations so far.[1]
Guidance scorecard · Q1 FY27 call
What Insecticides India Ltd's management guided
and where it ranks in Fertilizers & Agrochemicals
Fertilizers & Agrochemicals
RevenueQ1 FY27 call
0–10%- Expect stronger execution and growth from Q2 onwards as delayed monsoons normalize.
- Target to double sales in 4 to 5 years compared to doubling in 3-4 years previously.
- Dahej and Sotanala expansions underway to support increased capacity and enable growth.
- New product launches (e.g., Granuvia, Spinoace) expected to contribute INR 30-35 crores in FY27.
- Focus on increasing premium product contribution from 64% to 70% in next 3-4 years.
- Kaeros Research growing rapidly with a targeted CAGR of 100% initially, then 50-60%.
- Working capital improvements and asset utilization optimization to boost returns.
2 more points from Insecticides India Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
FlatSee what Insecticides India Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Total investment for Sotanala formulation and technical plant: approx. INR 200 crores (INR 50 crores for formulation, INR 150 crores for technical). About INR 70 crores invested so far.
- Dahej facility fully commercialized (~70%), remaining parts soon. Sotanala plant Phase 1 expected completion by Diwali; Phase 2 under building erection stage.
- Sotanala technical plant to manufacture 5-6 identified insecticides and fungicides in Phase 1, with new AI technicals in Phase 2.
- Expansion is continuous with additional investment at Udhampur for dedicated herbicide and insecticide plants within this year.
- Post current projects, annual capex expected to normalize to INR 30-40 crores (maintenance capex).
2 more points from Insecticides India Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
See what Insecticides India Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
Ask what Insecticides India Ltd said on the order book →
Full Q1 FY27 analysisRanges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Dharmaj CropGood growth2
- Anya Polytech &Good growth1
- M B Agro Prod.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Fertilizers & Agrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | Anya Polytech & | 20–40% | Up 2%+ | ₹209 Cr | 25.1 |
| 2 | Dharmaj Crop | 20–40% | Up 0–2% | ₹882 Cr | 14.7 |
| 3 | M B Agro Prod. | 20–40% | Flat | ₹7,668 Cr | 49.5 |
| 4 | 20–40% | Flat | ₹6,453 Cr | 32.8 | |
| 5 | 10–20% | Up 2%+ | ₹1,226 Cr | 18.3 | |
| 6 | 10–20% | Flat | ₹51,882 Cr | 27.8 |
Sign up free to see every company in the sector ranking and track Insecticides India Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Fertilizers & Agrochemicals rankingFinancials of Insecticides India Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Insecticides India Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 357 | 302 | 640 | 696 | 358 | 272 | 657 | 627 | 358 | 359 | 691 | 638 | 385 |
| Expenses + | 333 | 331 | 594 | 614 | 332 | 264 | 585 | 538 | 327 | 330 | 607 | 548 | 358 |
| Operating Profit | 23 | -29 | 46 | 82 | 26 | 9 | 72 | 90 | 31 | 28 | 85 | 89 | 27 |
| OPM % | 7% | -9% | 7% | 12% | 7% | 3% | 11% | 14% | 9% | 8% | 12% | 14% | 7% |
| Other Income + | 0 | 0 | 4 | 0 | 1 | 5 | 3 | 2 | 0 | 3 | 4 | 3 | 1 |
| Interest | 5 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 2 | 4 | 4 | 5 |
| Depreciation | 6 | 7 | 7 | 7 | 7 | 8 | 7 | 7 | 8 | 7 | 7 | 9 | 9 |
| Profit before tax | 12 | -39 | 40 | 72 | 17 | 4 | 66 | 82 | 22 | 22 | 77 | 79 | 14 |
| Tax % | 25% | -25% | 26% | 26% | 28% | -106% | 25% | 25% | 22% | 37% | 25% | 25% | 27% |
| Net Profit + | 9 | -29 | 29 | 53 | 12 | 8 | 49 | 61 | 17 | 14 | 58 | 59 | 10 |
| EPS in Rs | 3.17 | -9.90 | 9.85 | 17.96 | 4.16 | 2.62 | 16.68 | 21.13 | 5.97 | 4.77 | 19.97 | 20.31 | 3.61 |
Financials of Insecticides India Ltd
Profit & Loss
Annual income statement trend
| Mar 2009 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 240 | 893 | 906 | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 | 2,000 | 2,073 |
| Expenses + | 211 | 782 | 814 | 882 | 925 | 1,006 | 1,207 | 1,268 | 1,333 | 1,679 | 1,804 | 1,779 | 1,843 |
| Operating Profit | 28 | 111 | 92 | 112 | 148 | 188 | 156 | 153 | 171 | 122 | 162 | 221 | 230 |
| OPM % | 12% | 12% | 10% | 11% | 14% | 16% | 11% | 11% | 11% | 7% | 8% | 11% | 11% |
| Other Income + | 1 | 0 | 0 | 7 | 3 | 1 | 3 | -2 | 3 | 1 | 10 | 8 | 11 |
| Interest | 4 | 33 | 26 | 20 | 16 | 15 | 24 | 7 | 7 | 13 | 11 | 7 | 15 |
| Depreciation | 1 | 15 | 16 | 16 | 17 | 20 | 24 | 25 | 26 | 26 | 29 | 29 | 33 |
| Profit before tax | 24 | 64 | 50 | 82 | 118 | 153 | 111 | 120 | 141 | 84 | 132 | 193 | 193 |
| Tax % | 14% | 14% | 21% | 27% | 29% | 20% | 22% | 21% | 24% | 25% | 23% | 26% | |
| Net Profit + | 21 | 55 | 40 | 60 | 84 | 123 | 87 | 94 | 107 | 63 | 102 | 142 | 142 |
| EPS in Rs | 7.34 | 19.24 | 12.77 | 19.26 | 27.19 | 39.62 | 28.04 | 30.29 | 36.29 | 21.36 | 34.49 | 48.81 | 48.66 |
| Dividend Payout % | 12% | 0% | 10% | 7% | 5% | 3% | 10% | 4% | 6% | 14% | 9% | 4% |
Financials of Insecticides India Ltd
Balance Sheet
Capital structure and asset base
| Mar 2009 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 30 | 30 | 29 | 29 |
| Reserves | 88 | 278 | 388 | 444 | 527 | 641 | 711 | 800 | 850 | 889 | 982 | 1,056 | 1,174 |
| Borrowings + | 14 | 322 | 206 | 237 | 114 | 305 | 191 | 100 | 54 | 163 | 87 | 105 | 246 |
| Other Liabilities + | 87 | 308 | 321 | 277 | 338 | 388 | 372 | 505 | 473 | 615 | 620 | 709 | 547 |
| Total Liabilities | 201 | 920 | 936 | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 1,997 |
| Fixed Assets + | 25 | 210 | 198 | 185 | 232 | 240 | 239 | 239 | 253 | 263 | 286 | 282 | 384 |
| CWIP | 1 | 38 | 51 | 58 | 17 | 19 | 39 | 59 | 91 | 123 | 142 | 161 | 81 |
| Investments | 17 | 3 | 3 | 11 | 17 | 12 | 12 | 14 | 16 | 17 | 23 | 29 | 31 |
| Other Assets + | 159 | 670 | 684 | 725 | 735 | 1,084 | 1,004 | 1,115 | 1,037 | 1,294 | 1,268 | 1,426 | 1,501 |
| Total Assets | 201 | 920 | 936 | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 1,997 |
Financials of Insecticides India Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2009 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 6 | -6 | 86 | 4 | 182 | -133 | 242 | 155 | 135 | -11 | 187 | 93 |
| Cash from Investing Activity + | -4 | -34 | -19 | -14 | -26 | -49 | -24 | -113 | 9 | -86 | -46 | -38 |
| Cash from Financing Activity + | -3 | 36 | -64 | 9 | -143 | 172 | -159 | -104 | -115 | 80 | -98 | -61 |
| Net Cash Flow | -1 | -4 | 4 | -0 | 13 | -11 | 59 | -61 | 30 | -17 | 42 | -5 |
| Free Cash Flow | -0 | -40 | 67 | -10 | 154 | -171 | 213 | 108 | 68 | -97 | 143 | 59 |
| CFO/OP | 32% | 1% | 108% | 19% | 140% | -54% | 175% | 120% | 103% | 16% | 124% | 61% |
Financials of Insecticides India Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2009 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50 | 68 | 84 | 78 | 80 | 75 | 86 | 65 | 70 | 60 | 55 | 70 |
| Inventory Days | 230 | 220 | 190 | 232 | 214 | 355 | 202 | 248 | 228 | 247 | 221 | 268 |
| Days Payable | 106 | 118 | 114 | 108 | 128 | 141 | 96 | 136 | 117 | 128 | 115 | 154 |
| Cash Conversion Cycle | 174 | 170 | 159 | 201 | 166 | 289 | 192 | 177 | 181 | 178 | 161 | 185 |
| Working Capital Days | 102 | 40 | 75 | 80 | 93 | 116 | 98 | 108 | 111 | 92 | 97 | 106 |
| ROCE % | 27% | 12% | 16% | 20% | 21% | 14% | 15% | 16% | 10% | 13% | 17% |
Guidance history
How Insecticides India Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 0–10% | Flat | Planned | — | — |
| Q4 FY26 call → | 10–20% | Up 0–2% | Planned | None planned | — |
| Q3 FY26 call → | 0–10% | Flat | Planned | — | — |
| Q2 FY26 call → | 10–20% | Flat | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
9 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −28.3% | 26% |
| Last 6 months | −26.9% | 10% |
| Last 3 months | −17.6% | 22% |
The price is 51% below its all-time high of ₹1,045.1 (25 Jul 2025). Stocks more than 20% below their peak have their score halved, so 19 became 9.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Insecticides India Ltd: 0.4 × 26 + 0.4 × 10 + 0.2 × 22 = 19, halved to 9 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Insecticides India Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Dhanuka Agritech Ltd (Q2 FY27)
657.51 Crores . Key investor presentation takeaways from Dhanuka Agritech Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.
- Sharda Cropchem Ltd (Q2 FY27)
1,051.7 Cr, up 13% YoY (Q2 FY26: Rs. Key investor presentation takeaways from Sharda Cropchem Ltd's Q2 FY27 investor presentation — and how it ranks against sec
- Paradeep Phosphates Ltd (Q2 FY27)
Revenue from operations for the quarter ended 30 September 2026: Rs 7,164.06 crores . Key results statement takeaways from Paradeep Phosphates Ltd's Q2 FY27 ear
- Astec Lifescienc (Q2 FY27)
2.3% YoY decline. Key results statement takeaways from Astec Lifescienc's Q2 FY27 results statement — and how it ranks against sector peers.